Le Lézard
Classified in: Health, Business
Subjects: LIC, PLW

New UDHI Announces Preliminary Agreement for Medical Patent


MAULDIN, S.C., Sept. 11, 2020 /PRNewswire/ -- Union Dental Holdings, Inc. (OTC: "UDHI", "New UDHI", "the Company") has announced that it has entered into a Preliminary Agreement with Consulting Group of Jocassee, Inc. The Agreement calls for execution of a Licensing Agreement for the world-wide rights to its recently granted Patent, #10,718,586, and other intellectual property owned by Consulting Group of Jocassee, Inc. as they pertain to the design, manufacture, and world-wide distribution of medical devices. The Agreement provides UDHIs' newly appointed Chief Science Officer and patent co-inventor, Dr. Anja Glisovic, with the intellectual property necessary to launch the first component of the Company's multi-tiered business development plan.

Patent #10,718,586 relates to metals or metal alloys used in construction of a gun barrel but has numerous applications in medical devices thereby giving this patent immediate commercial viability in the medical arena.

"This Agreement puts the New UDHI on the verge of generating significant revenues as we put the pieces in place to fully implement our acquisition and international growth strategy," said UDHI CEO Michael O'Shea. "Great appreciation goes out to my fellow Board member and patent co-inventor, Steve Gravely, who has been the driving force behind the creation and licensing of this extraordinary patent. We look forward to fully capitalizing on its many exciting new medical applications under the leadership of Steve's patent partner and our new CSO, Dr. Anja Glisovic."    

SAFE HARBOR
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

Media Contact: Adrienne Mazzone[email protected] 561-908-1683

SOURCE Union Dental Holdings, Inc.


These press releases may also interest you

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...

at 16:05
Illumina, Inc. announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as Corporate Senior Vice...

at 16:05
Peloton Interactive, Inc. ("Peloton") today announced that it intends to launch a global refinancing, pursuant to which it will offer $275.0 million aggregate principal amount of convertible senior notes due 2029 (the "notes") in a private offering...

at 15:52
Valisure LLC, a technology company that conducts independent chemical analysis of pharmaceuticals, filed an amended complaint in a recently...

at 15:30
Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), is proud to introduce the Solar Compact System and Solar Anorectal Manometry Catheter, the first disposable HRAM catheter on the market....



News published on and distributed by: